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ABSTRACT 27 
Purpose. This study aimed to (i) explore children’s compliance to wearing wrist and hip-28 
mounted accelerometers, (ii) compare children’s physical activity (PA) derived from wrist 29 
and hip raw accelerations, and (iii) examine differences in raw and counts PA measured by 30 
hip-worn accelerometry.  31 
Methods. One hundred and twenty nine 9-10 y old children wore a wrist-mounted 32 
GENEActiv accelerometer (GAwrist) and a hip-mounted ActiGraph GT3X+ accelerometer 33 
(AGhip) for 7 d. Both devices measured raw accelerations and the AGhip also provided 34 
counts-based data.  35 
Results. More children wore the GAwrist than the AGhip regardless of wear time criteria 36 
applied (p<.001 - .035). Raw data signal vector magnitude (SVM; r = .68), moderate PA 37 
(MPA; r = .81), vigorous PA (VPA; r = .85), and moderate-to-vigorous PA (MVPA; r = .83) 38 
were strongly associated between devices (p<.001). GAwrist SVM (p = .001), MPA (p = 39 
.037), VPA (p = .002), and MVPA (p = .016) were significantly greater than AGhip. 40 
According to GAwrist raw data, 86.9% of children engaged in at least 60 min MVPA∙d-1, 41 
compared to 19% for AGhip. ActiGraph MPA (raw) was 42.00 ± 1.61 min∙d-1 compared to 42 
35.05 ± 0.99 min∙d-1 (counts) (p=.02). Actigraph VPA was 7.59 ± 0.46 min∙d-1 (raw) and 43 
37.06 ± 1.85 min∙d-1 (counts; p=.19).  44 
Conclusion. In children accelerometer wrist placement promotes superior compliance than 45 
the hip. Raw accelerations were significantly higher for GAwrist compared to AGhip, 46 
possibly due to placement location and technical differences between devices. AGhip PA 47 
calculated from raw accelerations and counts differed substantially, demonstrating that PA 48 
outcomes derived from cutpoints for raw output and counts cannot be directly compared.  49 
Keywords: raw accelerations, wear time, physical activity, GENEActiv, ActiGraph GT3X+ 50 
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INTRODUCTION 51 
Accelerometry is the most widely used objective method of assessing children’s free-living 52 
physical activity (PA) (1). Accelerometers allow accelerations to be quantified, and in the 53 
context of PA research the accelerometer outcome is related to a measure of energy 54 
expenditure (12) or PA behaviour (17). Traditionally, accelerometers have been worn on the 55 
hip as this location is thought to provide the most accurate estimations of energy expenditure 56 
and activity intensity (26). Recently there has been an increased use of wrist-worn devices, 57 
which it has been argued, promote better compliance to device wear.  In the NHANES 2011-58 
12 data collection cycle using wrist-worn accelerometers, median wear time duration was 21-59 
22 hours per day, which was up to 100% longer than in previous cycles using hip-worn 60 
devices (28). Compared to hip-worn accelerometers, those worn on the wrist may be 61 
perceived as less burdensome to research participants, thus promoting wear-time compliance 62 
(21, 39). Variable compliance to accelerometer monitoring protocols influences the 63 
application of minimum wear time criteria (i.e., number of minutes wear that constitutes a 64 
‘valid’ day of measurement and the minimum number of days required for a reliable estimate 65 
of PA levels), which are subject to variation in researcher decisions about how ‘non-wear’ 66 
time is defined (33). Better compliance gives greater confidence that PA data are 67 
representative of actual daily PA due to the association between duration of monitoring and 68 
reliability of PA data (16). Presently though, there is limited evidence of the extent of 69 
improved compliance in children wearing accelerometers on the wrist.  70 
The growing popularity of the wrist as the accelerometer placement site warrants 71 
comparisons with PA data derived from devices worn on the hip, which has traditionally been 72 
the most commonly used site. Recently, PA intensity cutpoints derived from raw acceleration 73 
output have been developed in the same study for the GENEActiv (Activinsights, Cambs, 74 
UK) and ActiGraph GT3X+ (ActiGraph, Pensacola, FL) accelerometers, which are designed 75 
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for wear both on the wrist and hip (12).  Using these protocol-specific cutpoints together may 76 
help improve our understanding of how concurrent estimates of PA intensity from the wrist 77 
and hip sites compare. This move towards raw acceleration signal processing is a recent 78 
advance in accelerometer-based PA monitoring, which has traditionally used accelerometer 79 
output reduced to ‘counts’. Direct comparison of PA outcomes derived from different devices 80 
has not previously been possible due to differences in proprietary algorithms used to collect, 81 
process, filter, and scale raw signal data to produce the device-specific counts (3, 40). This 82 
lack of equivalency between devices and therefore comparability between studies using 83 
different devices, has led to the emergence of accelerometers such as the GENEActiv range 84 
and ActiGraph GT3X+ and GT9X. These devices are capable of collecting and recording 85 
raw, unfiltered accelerations which can then be subject to researcher-driven data processing 86 
procedures (40). Basing PA data on raw accelerations provides an opportunity to improve 87 
comparability between studies using different devices, and promote transparency and 88 
consistency of post-data collection analytical processes (12). Presently though, limited 89 
published research is available describing children’s free-living PA derived from raw 90 
accelerometer data. One study involving  47, 1st to 5th grade children wearing GENEActiv 91 
accelerometers on the wrist reported mean daily MVPA and VPA of 308.2 min and 32.7 min, 92 
respectively (31). In a sample of 58 Australian 10-12 year olds, MVPA derived from 93 
GENEActiv raw data was 67.8 min∙d-1 (hip) and 98.2 min∙d-1 (wrist) with VPA recorded as 94 
11.1 min∙d-1 (hip) and 16.7 min∙d-1 (wrist) (28). These studies however, calculated the signal 95 
vector magnitude values differently (i.e., averaging vs. summing raw accelerations per 96 
epoch), and used different PA intensity cutpoints (23, 31), which makes direct comparison of 97 
findings challenging. Another important issue is that historical accelerometer data used 98 
counts and extensive validation work has been conducted on counts-based accelerometer data 99 
(9, 17, 24, 35). Although the ‘cutpoint conundrum’ exists, there has been some consensus in 100 
5 
 
recent years for using the cutpoints of Evenson et al. (9), which have convincing evidence of 101 
validity in children (34). These cutpoints therefore provide a basis for free-living comparison 102 
with more contemporary cutpoints based on raw accelerations (12, 23, 31).  103 
As the field moves more towards utilisation of raw data processing and the availability of 104 
wrist-worn devices increases, studies reporting the comparability of PA outcomes based on 105 
raw accelerations and counts from both wrist and hip are warranted. Therefore, the aims of 106 
this study were (i) to explore children’s compliance to wearing wrist and hip-mounted 107 
accelerometers during free-living, (ii) to compare children’s PA derived from raw 108 
acceleration signals of wrist and hip worn accelerometers, and (iii) to examine differences in 109 
PA estimated from raw data with that from counts data measured by a hip worn 110 
accelerometer. 111 
METHODS 112 
Participants. The participants were 129 Year 5 (9-10 y) children (79 girls) from six primary 113 
schools in Liverpool, England. Following ethical approval from the University Research 114 
Ethics Committee, all Year 5 children (n = 326) in participating schools were invited to 115 
participate. They received a pack which contained parent and child information sheets, 116 
consent and assent forms, and a medical screening form. Written informed consent and assent 117 
was received from parents and their children, respectively before children could participate in 118 
the study. 119 
Anthropometrics. Stature and sitting stature were assessed to the nearest 0.1cm using a 120 
portable stadiometer (Leicester Height Measure, Seca, Birmingham, UK). Body mass was 121 
assessed to the nearest 0.1kg (Seca, Birmingham, UK). Body mass index (BMI) was 122 
calculated for each participant with BMI z-scores also assigned (4). Age and sex specific 123 
BMI cut points were used to classify children as normal weight or overweight/obese (5). 124 
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Gender-specific regression equations (20) were used to predict children’s age from peak 125 
height velocity (APHV), which is a proxy measure of biological maturation. All 126 
measurements were taken by the second author and a research assistant using standard 127 
procedures. 128 
Socio-economic status. Neighbourhood-level socio-economic status (SES) was calculated 129 
using the 2010 Indices of Multiple Deprivation (IMD) (7). The IMD is a UK Government 130 
produced measure comprising seven areas of deprivation (income, employment, health, 131 
education, housing, environment, and crime). Deprivation scores were generated using the 132 
National Statistics Postcode Directory database from parent reported home postcodes. Higher 133 
SES was represented by lower IMD scores. 134 
Physical Activity. Free-living PA was assessed using the GENEActiv Original triaxial 135 
accelerometer (Activinsights, Cambs, UK) worn on the non-dominant wrist (GAwrist) and 136 
the ActiGraph GT3X+ triaxial accelerometer (ActiGraph, Pensacola, FL) worn on the right 137 
hip (AGhip). The GENEActiv can be worn on the wrist, upper arm, hip, chest, ankle, and 138 
thigh, has a dynamic range of ± 8 g, and is a valid measure of PA in children (12, 23, 31). 139 
The GENEActiv was selected because it measures raw accelerations and is typically worn on 140 
the wrist (30, 31, 38, 39). ActiGraph accelerometers have been used in PA research for 141 
around 20 years and have been validated on several occasions with children (9, 19, 24, 35). 142 
The GT3X+ model has a dynamic range of ± 6 g, and can be worn on the hip, ankle, wrist, 143 
and thigh. The ActiGraph was selected as it is the most commonly used accelerometer in 144 
children’s PA research, and though it is being worn on the wrist in the most recent NHANES 145 
data collection cycles (28), traditionally it has been worn on the hip (26). The GT3X+ has the 146 
capability to generate raw acceleration and count data to enable straightforward backwards 147 
interpretation of data in either format. Both devices were initialised to record raw 148 
accelerations at a frequency of 100 Hz, and participants were asked to wear the monitors at 149 
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all times for 7 consecutive days except when sleeping and engaging in water based activities 150 
(e.g., bathing, swimming). Data collection took place during the regular school term from 151 
January to May 2014 so activities were representative of usual free-living activities. After 7 152 
days GAwrist data were downloaded using GENEActiv v.2.2 software (Activinsights, 153 
Cambs, UK) and saved in raw format as binary files. AGhip data were downloaded using 154 
ActiLife v. 6.11.4 (ActiGraph, Pensacola, FL) and saved in raw format as GT3X files. These 155 
were subsequently converted to CSV format to facilitate raw data processing, and to AGD 156 
format for analysis of counts data. GAwrist and AGhip raw data files were then processed in 157 
R (http://cran.r-project.org) using the GGIR package (version 1.1-4) which autocalibrated the 158 
raw triaxial accelerometer signals (37) and converted them into one omnidirectional measure 159 
of acceleration, termed the signal vector magnitude (SVM). SVM was calculated from raw 160 
accelerations from the three axes minus 1 g which represents the value of gravity (i.e., SVM 161 
= √(x2 + y2 + z2) – 1), after which negative values were rounded to zero. This metric has 162 
previously been referred to as the Euclidean norm minus one (ENMO) (38). Raw data were 163 
further reduced by calculating the average SVM values per 1-s epoch expressed in mg∙s-1 164 
over each of the 7 monitored days. 165 
 166 
AGhip and GAwrist raw data wear times were estimated on the basis of the standard 167 
deviation and value range of each axis, calculated for 60 min moving windows with 15 min 168 
increments (38). A time window was classified as nonwear time if, for at least 2 out of the 3 169 
axes, the standard deviation was less than 13.0 mg or if the value range was less than 50 mg 170 
(30). This approach has been applied previously in studies using both devices worn at the 171 
wrist and hip (27, 28, 38). For ActiGraph counts data, non-wear is conventionally determined 172 
from accumulated pre-determined time periods of consecutive zero counts. To address study 173 
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aim 3, and in keeping with previous work (10, 25), the 1-s epoch AGhip counts data non-174 
wear time was defined as at least 20 min periods of consecutive zero counts (2). 175 
 176 
Raw acceleration outcome variables for AGhip and GAwrist were average gravity-based 177 
SVM (mg), and min of MPA, VPA, and MVPA which were calculated using device and 178 
location-specific cutpoints based on the ENMO metric (12). These were 142.6 mg (MPA) 179 
and 464.6 mg (VPA) for AGhip, and 191.6 mg (MPA) and 695.8 mg (VPA) for GAwrist 180 
(12). Comparing PA values based on ENMO-derived SVM was important as this metric was 181 
applied to ActiGraph GT3X+ and GENEActiv  data in the same calibration study (12). For 182 
analysis of raw acceleration and counts-based PA levels, inclusion criteria were at least 10 183 
h∙day-1 wear time for at least three days, including a minimum of one weekend day. This 184 
resulted in analytical samples of 84 participants for the GAwrist vs. AGhip raw data analyses, 185 
and 65 participants for the AGhip raw vs. counts data analyses. Outcome variables for AGhip 186 
counts data were min of MPA, VPA, and MVPA which were classified according to 187 
empirical cutpoints (9) that have demonstrated acceptable classification accuracy across a 188 
range of intensities in children (34). Presently, no published sedentary time cutpoints exist for 189 
GAwrist and AGhip raw accelerations calculated using the ENMO approach. For this reason 190 
we did not investigate differences in sedentary time and light intensity PA. 191 
 192 
Analysis. Kolmogorov-Smirnov tests confirmed that raw PA outcome data for the overall 193 
week and week days were normally distributed but that weekend GAwrist SVM and VPA, 194 
weekend AGhip SVM, MVPA, and VPA, and AGhip counts data had skewed distributions 195 
(p<.05). Following log (SVM, MVPA), square root (VPA), and reciprocal (AGhip counts 196 
MPA, VPA, MVPA) transformations, data were normalized and included for analyses. All 197 
transformed data were back-transformed for presentation purposes. To analyse compliance 198 
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(study aim 1), mean daily valid wear time and number of valid days were calculated for 199 
GAwrist and AGhip raw data. Paired samples McNemar’s tests and t-tests assessed 200 
compliance and wear time differences against differing wear time criteria. To address study 201 
aim 2, partial Pearson correlation analyses assessed raw data relationships between devices 202 
for SVM, MPA, VPA, and MVPA, while controlling for the effects of wear time. Bland-203 
Altman plots were constructed to assess agreement between device raw data outputs, and 204 
repeated measures ANCOVAs compared raw data PA outcomes between AGhip and 205 
GAwrist for the whole week, week days, and weekend days.  For aim 3, repeated measures 206 
ANCOVAs examined differences between whole week reciprocal transformed MPA, VPA, 207 
and MVPA derived from AGhip raw and from counts data. In each ANCOVA adjustment 208 
was made for device wear time and sex. Statistical significance was set to p<.05. All analyses 209 
were conducted using IBM SPSS Statistics version 22 (IBM, Armonk, NY). 210 
RESULTS 211 
Descriptive characteristics of the participants are displayed in Table 1. Around three-quarters 212 
of the children were of healthy weight which is typical for Liverpool but somewhat lower 213 
than the English national average. Boys and girls were similarly aged but girls were more 214 
advanced than boys in regards to somatic maturation. IMD scores indicated that participants 215 
resided in some of the lowest SES neighbourhoods in England.  216 
TABLE 1 HERE 217 
Raw data device compliance  218 
AGhip and GAwrist data were available for 115 and 128 children, respectively. Instances of 219 
device malfunction (n=1), software errors (n=5), and accelerometer non-wear (n=8) 220 
accounted for the modest data attrition. The percentage of children that wore each device for 221 
between 6 and 12 h∙d-1 on 1 to 7 d is presented in the Supplemental Digital Content (see 222 
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Table, Supplemental Digital Content 1). Over 95% of children wore the AGhip and GAwrist 223 
for at least 12 h on a single day. Irrespective of the number of monitoring days, the 224 
percentage of children wearing both devices decreased with hours of wear, and this drop-off 225 
was more prominent for the AGhip. For example, the difference in the proportion of children 226 
wearing the AGhip for 6 h over 3 days and those wearing it for 12 h over 3 d was -18.3%, 227 
compared to -5.8% for the GAwrist. Ten h wear time over at least 2 d has been demonstrated 228 
to provide reliable estimates of PA in population studies of older primary school aged 229 
children (25). Taking 10 h wear time as the criterion for a valid day, the decrease in children 230 
wearing the AGhip for between 1 and 7 d was 80.5%, in comparison to 62.0% for the 231 
GAwrist. A similar trend was observed when the inclusion of at least one weekend day was 232 
considered. With inclusion criteria of a minimum of 10 h wear on at least 3 weekdays plus a 233 
minimum of one weekend day, GAwrist non-compliance (16.4%) was lower than for the 234 
AGhip (25.2%). 235 
 236 
When the number of children classified as ‘included’ as defined by commonly used wear 237 
time criteria (25) were analysed, significantly more children achieved wear time criteria when 238 
wearing the GAwrist than the AGhip for at least 9 h∙d-1 (p=.002) and 10 h∙d-1 (p=.035) on any 239 
4 d of the week (Table 2). When a weekend day was included in the criteria this level of 240 
compliance was achieved by significantly more children wearing the GAwrist than the AGhip 241 
for either 9 h∙d-1 or 10 h∙d-1 over 2, 3, and 4 week days (p=.001-.002). Average daily wear 242 
time across the different wear time criteria ranged from 15.57 to 15.82 h∙d-1 for the GAwrist, 243 
and 14.18 to 14.21 h∙d-1 for the AGhip. GAwrist daily wear time was significantly higher 244 
than for the AGhip, regardless of wear time criteria applied (p<.001). Children wore the 245 
GAwrist for significantly more days than the AGhip. When a valid day was defined as at 246 
least 9 h wear, the GAwrist was worn for 5.8 d out of 7 d compared to 5.1 d for the AGhip 247 
11 
 
(p<.001), and for 5.6 d versus 4.9 d when 10 h wear was the criterion (p<.001). During 248 
weekdays the GAwrist was worn for 4.2 d (9 h) and 4.1 (10 h) in comparison to 3.8 d 249 
(p<.001) and 3.7 d (p<.001) respectively, for the AGhip. The GAwrist was also worn most at 250 
weekends when valid day minimum wear was set to 9 and 10 h (GAwrist: 1.6 d and 1.5 d, 251 
respectively; AGhip: 1.3 d and 1.2 d, respectively; p<.001).  252 
TABLE 2 HERE 253 
Raw data physical activity levels 254 
Significant partial correlations between raw data PA outcomes confirmed that after 255 
adjustment for wear time, SVM (r = .68), MPA (r = .81), VPA (r = .85), and MVPA (r = .83) 256 
were moderately to strongly associated between devices (p<.001). Bland-Altman plots are 257 
presented in Figure 1A-D and show that the extent of differences in SVM, MPA, VPA, and 258 
MVPA between GAwrist and AGhip increased linearly with children’s levels of PA 259 
engagement. Correlation coefficients between the mean of the measures and the bias were r = 260 
.75 (SVM), r = .64 (MPA), r = .75 (VPA), and r = .69 (MVPA), indicating that the 95% limits 261 
should be treated with caution.  262 
FIGURE 1A-D HERE 263 
 264 
Comparisons of PA levels between devices are presented in Table 3. Wear time and sex-265 
adjusted SVM values during the whole week, weekdays, and weekend days were 266 
significantly higher for the GAwrist than the AGhip (p=.001). MPA recorded by the GAwrist 267 
on weekdays, weekend days, and over the whole week was 45.2% (p=.07), 41.1% (p=0.1), 268 
and 44.2% (p=.04) greater respectively, than values derived from the AGhip. GAwrist VPA 269 
was also significantly higher than AGhip at the different times of the week (p=.02 - .001), 270 
with the greatest difference of 54.7% occurring at weekends. MVPA was 43.3-45.7% greater 271 
for the GAwrist than the AGhip across the whole week, week days, and weekend days. 272 
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According to the GAwrist raw data, 86.9% of children engaged in at least 60 min MVPA∙d-1, 273 
compared to 19% according to AGhip-derived MVPA.  274 
TABLE 3 HERE 275 
Physical activity levels from AGhip raw and counts data 276 
Analyses of raw and counts data for AGhip revealed that children’s adjusted whole week 277 
MPA (raw) was 42.00 ± 1.61 min∙d-1 compared to 35.05 ± 0.99 min∙d-1 (counts) (p=.02), a 278 
difference of 16.5% (Figure 2). Adjusted VPA differed by 79.5% between counts (37.06 ± 279 
1.85 min∙d-1) and raw data (7.59 ± 0.46 min∙d-1; p=.19). These combined MPA and VPA 280 
differences were reflected in overall MVPA (72.11 ± 2.60 min∙d-1 [counts] vs. 49.59 ± 2.01 281 
min∙d-1 [raw]; p=.57). The recommended 60 min∙d-1 of MVPA was achieved by 20.2% and 282 
67.7% of children with valid raw and counts data, respectively. 283 
FIGURE 2 HERE 284 
DISCUSSION 285 
In 2009 experts in PA measurement recommended that researchers’ estimations of PA should 286 
in future be based on raw acceleration data rather than proprietary movement counts (11). 287 
Since then raw accelerometer data have been reported more frequently, but still much less 288 
often than counts data. This study adds to the raw accelerometer data evidence base, as it is 289 
the first to examine children’s compliance to wrist and hip-worn devices, between-device 290 
differences in PA intensities derived from raw accelerations, and differences in hip-mounted 291 
ActiGraph GT3X+ raw acceleration versus counts-based estimates of free-living PA. 292 
Accelerometer compliance 293 
More children wore the GAwrist than AGhip irrespective of the wear time inclusion criteria 294 
applied or time of week observed. Using the wrist as the accelerometer placement site may 295 
promote better device compliance, as illustrated by the improved wear time reported in the 296 
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2011-12 NHANES data collection cycle (28). There is though a paucity of research 297 
investigating children’s compliance to wrist and hip-worn accelerometers worn in parallel. 298 
While it has been suggested that children (32) and adults (39) prefer the wrist as the device 299 
placement site, such preferences may be partly dependent upon specific device features (e.g., 300 
feedback on activity (32)) and monitor-specific wear instructions (e.g., removal of hip-worn 301 
devices during sleep and water-based activities (39)). This latter point is exemplified by a 302 
recent examination of hip-worn ActiGraph data from 9-11 y olds across 12 countries, which 303 
reported how a 24 h accelerometer wear protocol resulted in an average wear time of 22.6 h 304 
(36). Thus, asking children to only remove devices for water-based activities elicits much 305 
greater total wear times than are typically observed in waking time protocols. Waking wear 306 
time though was 14.7 h∙d-1 (36) which was similar to the AGhip values and less than the 307 
GAwrist values observed in our study. These findings confirm the combined influences of 308 
wear location and protocol on accelerometer wear compliance. To our knowledge no 309 
previous studies have examined children’s compliance to wearing wrist and hip-mounted 310 
accelerometers concurrently. Our findings confirm that children’s perceived acceptability of 311 
and preference for wrist-worn devices (32), reflect actual wear when children were asked to 312 
use two devices under the same conditions. Where feasible, future youth PA studies should 313 
employ wrist-worn accelerometry to increase the likelihood of longer wear time which would 314 
result in more representative and reliable estimates of PA (16). Wrist-worn devices may not 315 
only result in superior compliance, but according to recent evidence, may also provide better 316 
estimates of children’s energy expenditure compared to hip mounted accelerometers (6). For 317 
wrist-worn accelerometry to become widely adopted however, more needs to be known about 318 
the comparability of children’s PA levels derived from raw accelerations, with historical 319 
counts-based data.  320 
PA derived from raw acceleration signals of wrist and hip worn accelerometers 321 
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Correlations between wrist-worn GENEActiv and hip-worn ActiGraph free-living raw 322 
accelerations have not previously been reported in children. We observed moderate to strong 323 
partial correlations between AGhip and GAwrist (r = .68-.85) which were lower than the 324 
recently reported correlation of r = .93 between hip worn GENEActiv and ActiGraph GT3X+ 325 
average accelerations (27). Our findings indicate that both devices measured children’s free-326 
living accelerations which explained almost 70% of the shared variance in MVPA. 327 
Notwithstanding these strong associations, there were considerable differences between 328 
devices in average SVM and the derived outcomes (time spent in MPA, VPA, and MVPA). 329 
GAwrist values were consistently higher than those from the AGhip, particularly at higher 330 
intensities. These differences were most extreme for SVM values (~60%) which were 331 
calculated for both devices using identical data processing methods. In the only previous 332 
study to compare children’s raw GAwrist and AGhip data using the ENMO data processing 333 
approach, GAwrist SVM was significantly higher for a range of moderate-to-vigorous 334 
activities performed during a controlled device calibration protocol (i.e., fast walking, 335 
stepping, running, and circuit training) (12). Moreover, in agreement with our MPA and VPA 336 
results, greater relative differences between AGhip and GAwrist SVM values were observed 337 
as activity intensity increased (12). Similar differences between devices worn at the same site 338 
have previously been reported in adults as well as children regardless of analytical 339 
approaches used to generate raw accelerations (15, 27, 28). During vigorous ambulatory 340 
activities such as fast running, higher accelerations at the wrist relative to the hip may be 341 
observed due to greater shoulder muscle activity, compared to during walking and slow 342 
running, when arm swing and resultant wrist accelerations are more passive (29). Moreover, 343 
wrist accelerations will be disproportionately greater than those of the hip for certain types of 344 
movements that may occur regularly during children’s free-living activity (e.g., some sports, 345 
computer gaming, homework), and for example among children who gesticulate vigorously 346 
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(28). This ‘decoupling’ of wrist and hip accelerations may also occur in reverse (e.g., walking 347 
with hands in pockets) and is likely population-specific (28). We did not record the children’s 348 
activity modes but it may be feasible that their daily activities involved a disproportionate 349 
volume of ‘pro-wrist’ decoupling of wrist and hip accelerations, which contributed to higher 350 
GAwrist values. 351 
 352 
Although device placement location is arguably the most obvious reason why PA outcomes 353 
differed to the extent that they did, the strong inter-device associations between outcomes 354 
suggest that placement was not the only reason. Raw acceleration data from each device were 355 
used to generate the PA outcomes, but data cannot be considered equivalent (40), as raw 356 
accelerations for the GENEActiv have been observed to be greater than those for the 357 
ActiGraph GT3X+ when worn at the same site in controlled and free-living conditions (15, 358 
27, 29). For example, during mechanical shaker testing GENEActiv peak accelerations were 359 
up to 7.4% greater than ActiGraph GT3X+ with  differences increasing in line with shaker 360 
acceleration magnitude (15). Similarly, average GENEActiv high-pass filtered accelerations 361 
were recently observed to be over 10% greater than ActiGraph GT3X+ accelerations when 362 
both devices were worn at the hip during children’s free-living activities (27). Technical 363 
differences between devices, such as the micro-electro-mechanical sensors used and their 364 
dynamic ranges, reference voltage, analogue-to-digital conversion rate, and ActiGraph’s 365 
proprietary data filtering processes (14, 15, 27), are the likely explanations of the differences 366 
in each device’s acceleration outputs.  367 
 368 
Comparison of raw and counts PA data measured by a hip-mounted accelerometer 369 
Systematic differences in AGhip PA outcomes from raw and counts data were not observed. 370 
Raw data MPA values were 15.9% higher than counts data, but raw data VPA values were 371 
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79.6% lower than counts data. To our knowledge, no previous study has compared hip-372 
mounted ActiGraph GT3X+ raw and counts data output in children. The closest comparison 373 
is provided by Rowlands and colleagues who compared ActiGraph GT3X+ counts data using 374 
the cutpoints of Evenson et al. (9) with GENEActiv raw data, with both devices worn at the 375 
hip (28). The comparison is based on the very strong associations between devices for MVPA 376 
measured at the hip (r=.93) (28). Rowlands et al.’s findings mirrored ours whereby raw data 377 
MPA was greater than counts data (56.7 vs. 32.3 min∙d-1), but was lower for VPA (11.1 vs. 378 
30.0 min∙d-1) (28). The magnitude of the differences though differed somewhat, which may 379 
relate to the different raw data processing procedures and raw acceleration cutpoints (23) 380 
applied between our study and that of Rowlands and colleagues (28). It is likely that 381 
comparable raw acceleration values reported by Rowlands et al. would have been higher than 382 
those observed in our study, due to differences in raw acceleration data processing (i.e., 383 
converting acceleration negative values to their absolute, summing acceleration values per 1-s 384 
epoch) (8, 12, 23). Moreover, the PA intensity cutpoints used in both studies were derived 385 
from different calibration protocols (12, 23), which may be a more influential factor on PA 386 
outcomes than placement site or device type (28). While some inferences about output 387 
differences can be made on the basis of raw acceleration data processing, the proprietary 388 
nature of the ActiGraph GT3X+ algorithm to convert raw acceleration into counts makes 389 
similar suppositions difficult. These findings demonstrate that raw acceleration and counts 390 
data cannot be directly compared because insufficient information is available about how 391 
counts are generated. This reinforces the calls of others (13, 18, 22) for transparent raw 392 
accelerometer data processing to become the norm so as to progress the field towards 393 
equivalency of data output and better scope for comparability of findings between studies 394 
using different devices.  395 
 396 
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A strength of this study is that it is the first to assess children’s free-living PA derived from 397 
raw wrist and hip accelerations using the GENEActiv and ActiGraph GT3X+ accelerometers, 398 
respectively. Further, for the first time, children’s compliance to wearing these devices 399 
concurrently over a 7-d monitoring protocol has been reported. Wearing the accelerometers 400 
in parallel standardizes possible confounding variables such as the type of PA performed 401 
during the monitoring period (39). Raw acceleration data were processed and analysed using 402 
the same open source procedures which adds transparency and consistency to the data. The 403 
study sample was though limited to 9-10 y olds in a low socioeconomic area of England and 404 
our findings should be interpreted and applied with this in mind as free-living PA routines 405 
may be different for other age groups and for children from geographic locations. A further 406 
limitation is that data were collected during school term times and so may not be 407 
representative of PA during extended non-school time such as school holidays and vacations. 408 
We also did not report time spent being sedentary or in light intensity PA. Children’s 409 
sedentary time and light PA are associated with various health outcomes but presently, raw 410 
acceleration thresholds for GENEActiv and ActiGraph GT3X+ based on the ENMO metric 411 
do not exist, and so we were limited to reporting MPA, VPA, and MVPA.  412 
 413 
During free-living activity children had significantly better compliance to wearing the 414 
GAwrist than AGhip. The recognised association between duration of monitoring and 415 
reliability of PA data means that better compliance gives researchers and research users 416 
greater confidence in the PA data reported. The superior compliance of the GAwrist confirms 417 
that the wrist is a feasible accelerometer placement location in children. Raw acceleration 418 
values derived using the same data processing procedures were significantly higher for 419 
GAwrist compared to AGhip. It is unclear why these disparities occurred but it was likely a 420 
combination of the effects of placement location and technical differences between the 421 
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GENEActiv and ActiGraph GT3X+. To address this, it has been recently suggested that 422 
differences in acceleration magnitude between GENEActiv and ActiGraph GT3X could be 423 
addressed by the application of an appropriate conversion factor to make values 424 
interchangeable between devices (27). For this approach to be effective standardized data 425 
processing procedures would need to be applied to the raw acceleration data collected. AGhip 426 
PA levels calculated from raw accelerations and counts differed substantially, particularly in 427 
respect of VPA. These findings demonstrate that regardless of device placement location raw 428 
output and counts cannot be directly compared because of the lack of information about the 429 
ActiGraph proprietary filtering algorithm applied to generate counts. Raw acceleration data 430 
processing potentially enables greater transparency, and comparability between studies using 431 
the same data processing methods, though comparisons to counts-based data are limited. 432 
From a health promotion perspective, current PA guidelines are mainly based on self-report 433 
questionnaires and to a lesser extent, data from hip mounted accelerometer counts. As the use 434 
of raw acceleration data increases, examination of activity-health relationships using raw data 435 
from wrist mounted devices is warranted. We used the ENMO metric to calculate SVM but 436 
presently no SVM thresholds for children’s light PA and sedentary time exist using this 437 
method. Future work should include development of these thresholds which may help 438 
enhance our understanding of the influence of device type and placement location on 439 
children’s free-living raw accelerations and associated health outcomes. 440 
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FIGURE CAPTIONS 554 
Figure 1A-D. Bland-Altman plots displaying agreement between AGhip and GAwrist derived 555 
(A) SVM, (B) MPA, (C) VPA, and (D) MVPA. Note. The observed positive bias indicates 556 
that GAwrist values were higher than AGhip. Horizontal lines represent mean bias and 95% 557 
limits of agreement. 558 
Figure 2. Whole week MPA and VPA according to AGhip counts and raw data (n = 65) 559 
* AGhip raw MPA > AGhip counts MPA, p=.02  560 
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